News
HealthDay on MSN20h
ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 DiabetesThe oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback